NaijaBody
Dual GIP/GLP-1 Agonist
Most Popular

Tirzepatide

Same active ingredient as Mounjaro and Zepbound

significant average body weight loss in clinical trials

Weekly injection

Nigeria's
#1 Choice

What is Tirzepatide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist — the first medication to activate both incretin receptors. This dual action makes it more effective than single-action GLP-1 medications like Semaglutide.

GLP-1 Action

Reduces appetite, slows gastric emptying, and improves insulin sensitivity — same as Semaglutide.

GIP Action (Unique)

Enhances fat metabolism, improves nutrient absorption, and provides additional appetite suppression.

By activating both pathways, Tirzepatide delivers:

  • Superior weight loss — Up to significant average in clinical trials
  • Enhanced appetite control — Dual mechanism = stronger effect
  • Better metabolic health — Improved blood sugar and lipid profiles
  • Faster results — Many see significant changes in 4-8 weeks

Clinical Results: Published clinical research demonstrates that tirzepatide, as a dual GIP/GLP-1 receptor agonist, produces significant weight loss results in clinical trials. This dual-pathway mechanism represents a major advancement in weight management therapy.

Tirzepatide vs Semaglutide: significant vs 15% average weight loss — nearly 50% more effective

Available Doses

We stock all standard Tirzepatide doses. Start with 2.5mg and increase monthly for optimal results.

2.5

2.5mg

Starter dose (Month 1)

5.0

5.0mg

First increase (Month 2)

7.5

7.5mg

Therapeutic dose (Month 3)

Popular
10

10mg

High efficacy dose (Month 4+)

Higher doses (12.5mg, 15mg) available upon request for advanced users.

Dosing Schedule

Tirzepatide is injected once weekly, on the same day each week. Unlike Semaglutide, dose increases occur monthly (every 4 weeks) rather than weekly.

Month
1

2.5mg weekly

Your body adjusts to the medication. Mild effects expected.

Month
2

5.0mg weekly

Appetite suppression becomes noticeable. Weight loss begins.

Month
3

7.5mg weekly

Therapeutic dose. Significant appetite control and weight loss.

Month
4+

10mg weekly (or higher)

Maximum effect dose. Can increase to 12.5mg or 15mg if needed.

Pro tip: Many users find 7.5mg or 10mg sufficient for their weight loss goals. There's no need to rush to higher doses — find what works for you.

Side Effects

Side effects are similar to Semaglutide but may be milder for some due to the different receptor profile. The monthly titration schedule also helps reduce GI effects.

Common (may affect up to 1 in 10)

  • Nausea — Most common, usually improves after 2-4 weeks
  • Diarrhea — Stay hydrated, usually temporary
  • Decreased appetite — This is the intended effect!
  • Constipation — Increase fiber and water intake
  • Injection site reactions — Rotate injection sites

Less Common (seek medical advice)

  • Severe abdominal pain — May indicate gallbladder issues
  • Signs of pancreatitis — Severe pain radiating to back
  • Vision changes — Report any blurred vision
  • Allergic reactions — Rash, difficulty breathing

Good to know: Many users report that Tirzepatide causes less nausea than Semaglutide. The monthly (vs weekly) dose increases give your body more time to adjust.

Nigeria's #1 Choice for Weight Loss

Ready to Start Your Transformation?

Order Tirzepatide online. We deliver across Nigeria with discreet packaging. Most customers start seeing results within 4 weeks.

Order